GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make the process of switching from a compounded GLP-1 to a brand-name GLP-1 ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

In the UK, anxiety, panic attacks and insomnia are not listed as possible side-effects for Ozempic, Wegovy or Mounjaro.

Omada Health closed 21% higher in its Nasdaq debut after raising $150 million. Backed by strong growth and GLP-1 momentum, ...

HANNAH Metcalfe caught a whiff of something very unpleasant and felt her cheeks flush red. “It’s him, he’s farted!” she ...

A Slimming World Consultant with over 11 years’ experience from Bedford says slimming clubs are needed more than ever despite ...

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead ...

WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society said the jabs could cause ...

Nurse practitioner Shawnda Dorantes says weight-loss drugs are “helping people reclaim their health and confidence like never ...

EMA’s safety committee concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus & Wegovy: Amsterdam, The Netherlands Monday, June 9, 2 ...

The European Medicines Agency has indicated that Novo Nordisk's drugs, Ozempic and Wegovy, may rarely cause a serious eye ...

The British Menopause Society (BMS) has advised doctors to closely monitor patients taking HRT for menopause while also using ...